Biotin±protein ligase is an enzyme that catalyzes the ATP-dependent biotinylation of a speci®c lysine residue in acetyl-CoA carboxylase. The biotin±protein ligase from Pyrococcus horikoshii OT3 has been cloned, overexpressed and puri®ed. Crystallization was performed by the microbatch method or the vapour-diffusion method using PEG 2000 as a precipitant at 295 K. X-ray diffraction data have been collected to 1.6 A Ê resolution from a native crystal and to 1.55 A Ê resolution from a selenomethionine-derivative crystal for multiple anomalous dispersion phasing using synchrotron radiation at 100 K. The native crystal belongs to the monoclinic space group P2 1 , with unitcell parameters a = 38.601, b = 78.264, c = 70.147 A Ê , = 101.48 . Assuming a homodimer per asymmetric unit gives a V M value of 2.14 A Ê 3 Da À1 and a solvent content of 42.5%. Cocrystals with biotin, ADP and biotinyl-5 H -AMP were prepared and diffraction data sets were collected to 1.6, 1.6 and 1.45 A Ê resolution, respectively.
Introduction
Biotin±protein ligase (BPL) mediates the biotinylation of acetyl-CoA carboxylase via the covalent attachment of biotin to a speci®c lysine residue of the biotin carboxyl carrier protein (BCCP), which is a core subunit of the carboxylase (Chapman-Smith & Cronan, 1999) . This is a two-step reaction: adenylated biotin is ®rst synthesized from the substrates biotin and ATP and the biotin moiety is then transferred to the speci®c lysine residue of BCCP. The reaction is highly conserved in all organisms, which is reinforced by the fact that BPLs from different species are able to recognize and correctly biotinylate carboxylases from widely divergent sources (Cronan & Wallace, 1995; Tissot et al., 1996) . A multienzyme complex, acetyl-CoA carboxylase, catalyzes key reactions in the ®rst committed step in fatty-acid biosynthesis, in which malonyl-CoA is formed from acetyl-CoA, Mg 2+ ATP and bicarbonate (Wakil et al., 1983) . In agreement with the biotin-dependent character of these reactions, not only the carboxylase enzymes but also the BPL is essential for survival (Chapman-Smith et al., 2001) . The genomes of Clostridium acetobutylicum, Lactococcus lactis, Halobacterium sp., Pyrococcus abyssii and P. furiosus have two BPL paralogues with and without the N-terminal DNA-binding domain (Rodionov et al., 2002) . When BPL contains the N-terminal domain it can also act as a transcriptional repressor that regulates the biosynthesis of biotin. To date, only the crystal structure of BPL from Escherichia coli (EcBirA) has been reported (Wilson et al., 1992) . EcBirA, a bifunctional enzyme repressor, consists of three domains of 35.3 kDa in total: an N-terminal helix±turn±helix DNA-binding domain, a central catalytic domain and a C-terminal domain (Becket & Matthews, 1997) . The catalytic and C-terminal domains of EcBirA show 32% sequence identity to the BPL from P. horikoshii OT3 (PhBPL). The amino acids consistent with the N-terminal 60 residues of EcBirA reported as a DNA-binding domain are absent in PhBPL. Therefore, in contrast to EcBirA, PhBPL is considered to be an enzyme with no transcriptional regulatory function. In this paper, we report the expression, puri®cation and preliminary crystallographic analysis of PhBPL and its compexes with the ligands biotin, ADP and biotinyl-5 H -AMP. Knowledge of these three-dimensional structures of BPL could help in understanding the reaction mechanisms of BPL and # 2005 International Union of Crystallography All rights reserved acetyl-CoA carboxylase at the molecular level and what it is that structurally distinguishes between the enzyme PhBPL and the bifunctional enzyme repressor EcBirA.
Experimental

Protein expression and purification
The biotin±protein ligase from P. horikoshii OT3 (PhBPL) used in this study has a molecular weight of 26.07 kDa and consists of 235 amino-acid residues. The plasmid encoding PhBPL was digested with NdeI and BglII and the fragment was inserted into the expression vector pET-11a (Novagen) linearized with NdeI and BamHI. E. coli BL21 Codon Plus (DE3)-RIL cells were transformed with the recombinant plasmid and grown at 310 K in Luria±Bertani medium containing 50 mg ml À1 ampicillin for 20 h. The cells were harvested by centrifugation at 4500g for 5 min at 277 K, suspended in 20 mM Tris± HCl pH 8.0 containing 0.5 M NaCl, 5 mM 2-mercaptoethanol and 1 mM PMSF and ®nally disrupted by sonication and heated at 363 K for 11.5 min. The cell debris and denaturated protein were removed by centrifugation at 20 000g for 30 min. The supernatant solution was used as the crude extract for puri®cation. The crude extract was desalted with a HiPrep 26/10 desalting column (Amersham Biosciences) and applied onto a Super Q Toyopearl 650M (Tosoh) column equilibrated with 20 mM Tris±HCl pH 8.0 (buffer A). After elution with a linear gradient of 0±0.3 M NaCl, the fraction containing PhBPL was desalted with a HiPrep 26/10 desalting column with 10 mM potassium phosphate pH 7.0. The sample was then applied onto a Bio-Scale CHT-20-I column (Bio-Rad) equilibrated with 10 mM potassium phosphate pH 7.0 and eluted with a linear gradient of 10±300 mM potassium phosphate pH 7.0. The sample was concentrated by ultra®ltration (Vivaspin, 5 kDa cutoff) and loaded onto a HiLoad 16/60 Superdex 200 prep-grade column (Amersham Biosciences) equilibrated with buffer A containing 0.2 M NaCl. The homogeneity and identity of the puri®ed sample were assessed by SDS±PAGE (Laemmli, 1970) and N-terminal sequence analysis. Finally, the puri®ed PhBPL was concentrated to 9.87 mg ml À1 (based on the absorption coef®cient of 24 675 cm À1 M À1 at 280 nm and the molecular weight of 26 071 Da) using ultra®ltration and stored at 203 K. Selenomethionine (SeMet) substituted protein was prepared in an analogous way and its preparations showed virtually identical results to those of the native protein.
Dynamic light-scattering study
The oligomerization state of the puri®ed PhBPL was examined by a dynamic light-scattering experiment using a DynaPro MS/X instrument (Protein Solutions). This was performed at a protein concentration of 9.87 mg ml À1 in 20 mM Tris±HCl pH 8.0 with 500 mM NaCl. Several measurements were taken at 291 K and analyzed using the DYNAMICS software v.3.30 (Protein Solutions). The result showed a sharp monomodal pro®le centred at 3.23 nm radius corresponding to a molecular weight of 53.9 kDa, suggesting a dimeric state for PhBPL in solution.
Crystallization and X-ray data collection
Initial crystallization conditions for PhBPL were established using the TERA (automatic crystallization) system (Sugahara & Miyano, 2002) from 144 independent conditions. Crystals were obtained by the microbatch method using Nunc HLA plates (Nalge Nunc International). Each crystallization drop was prepared by mixing 1.0 ml precipitant solution (10.5% PEG 2000, 0.1 M acetate±NaOH pH 5.5) and 1.0 ml protein solution at 9.87 mg ml À1 . The crystallization drop was overlaid with a 1:1 mixture of silicone:paraf®n oils, allowing slow evaporation of water in the drop, and stored at 295 K. Higher quality crystals were grown using the sitting-drop method with essentially identical conditions as above. X-ray diffraction data were collected from¯ash-cooled crystals at 100 K on a Rigaku R-AXIS V imageplate detector using synchrotron radiation at beamline BL26B1 of SPring-8, Japan. The crystals were¯ash-frozen using a cryoprotectant solution comprising 10.5% PEG 2000, 0.1 M acetate±NaOH pH 5.5 and 20%(v/v) glycerol. Each frame was exposed for 25 s with a 1 oscillation at a crystal-to-detector distance of 250 mm. Data were processed and scaled using HKL2000 (Otwinowski & Minor, 1997) .
Results
We have established the expression, puri®cation and crystallization of PhBPL. Crystals appeared about 4±5 d after setup and grew to approximate dimensions of 0.40 Â 0.15 Â 0.08 mm after two weeks (Fig. 1) . Data-collection statistics are summarized in Table 1 . Assuming two chains of PhBPL in the asymmetric unit gives a crystal volume per protein weight (V M ) of 2.14 A Ê 3 Da À1 and a solvent content of 42.5% (Matthews, 1968) . Attempts to obtain a molecularreplacement solution using the crystal structure of EcBirA (Wilson et al., 1992) , which shares 32% sequence identity with PhBPL, did not yield any obvious solution. The high-quality selenomethioninederivative crystals allowed us to apply the multiple anomalous dispersion (MAD) method (Hendrickson et al., 1990) and to obtain the crystal structure of PhBPL at atomic resolution. Crystals also grew in the presence of 5 mM concentrations each of biotin, of ADP and of a combination of ATP and biotin, which provided biotin-, ADP-and biotinyl-5 H -AMP-bound forms, respectively. The ligandbound crystals diffracted well and the diffraction data sets were collected (Table 1) . To determine the crystal structure, a complete MAD data collection from a SeMet-derivative crystal was performed and the program SOLVE (Terwilliger & Berendzen, 1999 ) was used to ®nd six selenium sites out of the ten possible. On the basis of phases obtained from the MAD experiment, the structure was built and re®ned and the coordinates have been deposited in the PDB with code 1wq7. The solutions of the liganded forms of the enzyme with biotin, ADP and biotinyl-5 H -AMP that correspond to distinct functional states have been obtained by difference Fourier analyses. A detailed discussion of the structures will be published elsewhere.
